Description
Europe Hospice and Palliative Care Center market size is expected to grow at a prominent growth rate X% CAGR during the forecast period 2022 to 2028. The European market provides a detailed overview of the Europe Hospice and Palliative Care Center market, and that can be segmented by type of service, by end-user. By type of service, The Europe Hospice and Palliative Care Center market has been segmented into Cancer, Cardiac and Circulatory, Dementia, and Others. The Cardiac and Circulatory segment is likely to be the significant growing segment in terms of the type of service. The supremacy of this segment is due to an increase in the aging population in the region and the rising demand for home-based care settings. Various equipment can be used for diagnostic, therapeutic, and mobility assistance. Technologically advanced products that allow precise and timely diagnoses, such as iPhone heart-rate monitors, strapless heart rate monitors, and QTR heart-rate watches, are probable to push segment growth. The market by services consists of unskilled home care and skilled home care. Skilled home care services are offered by healthcare professionals. The elderly population facing diseases, such as cardiovascular disorders or diabetes, looking for medical assistance is propelling the market. Additionally, the growing prevalence of lifestyle diseases has raised the requirement for coordinated and continuous care services for home-bound patients improving from acute illness or injury. Moreover, skilled nursing services evade needless hospital stays for family and patient caregivers and decrease significant medical expenditure by giving the same standard of care at a lower cost. Based on the End user, the Europe Hospice and Palliative Care Center market is segmented into Home Settings, Smart Hospital, Specialty Nursing Homes, and Hospice Care Centres. Among these, the Specialty Nursing Homes segment is expected to have a significant growing market during the forecast period 2022-2028.
Key Developments:
In In March 2019, HB Healthcare was acquired by ResMed, solidifying its place as the market leader in Korea.